Oramed Pharmaceuticals Ownership | Who Owns Oramed Pharmaceuticals?
Oramed Pharmaceuticals Ownership Summary
Oramed Pharmaceuticals is owned by 7.99% institutional investors, 10.62% insiders, and 81.39% retail investors. Bml capital management is the largest institutional shareholder, holding 6.46% of ORMP shares. RBC Microcap Value I is the top mutual fund, with 0.21% of its assets in Oramed Pharmaceuticals shares.
ORMP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Oramed Pharmaceuticals | 7.99% | 10.62% | 81.39% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bml capital management | 2.64M | 6.46% | $6.40M |
| Murchinson | 1.75M | 4.28% | $4.24M |
| Boothbay fund management | 845.19K | 2.07% | $2.05M |
| Rathbones group | 289.80K | 0.71% | $701.32K |
| Two sigma advisers, lp | 241.40K | 0.59% | $584.19K |
| Bank of america corp /de/ | 173.24K | 0.43% | $445.23K |
| Renaissance | 151.81K | 0.37% | $367.38K |
| Dimensional fund advisors lp | 119.00K | 0.29% | $287.97K |
| Ubs group | 112.98K | 0.28% | $273.41K |
| Two sigma investments, lp | 110.38K | 0.27% | $267.12K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bml capital management | 2.64M | 3.97% | $6.40M |
| Murchinson | 1.75M | 1.81% | $4.24M |
| Boothbay fund management | 845.19K | 0.05% | $2.05M |
| Sage capital management | 16.75K | 0.02% | $40.53K |
| World equity group | 20.00K | 0.01% | $48.40K |
| Glass jacobson investment advisors | 10.54K | 0.01% | $25.51K |
| Rathbones group | 289.80K | 0.00% | $701.32K |
| Wealthfront advisers | 8.69K | 0.00% | $974.14K |
| N.e.w. advisory services | 12.36K | 0.00% | $29.91K |
| Two sigma advisers, lp | 241.40K | 0.00% | $584.19K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bml capital management | 2.64M | 3.97% | 457.72K |
| Ubs group | 112.98K | 0.00% | 84.80K |
| Royal bank of canada | 85.53K | - | 81.30K |
| Dimensional fund advisors lp | 119.00K | 0.00% | 70.19K |
| Murchinson | 1.75M | 1.81% | 42.08K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bank of america corp /de/ | 173.24K | - | -113.81K |
| Renaissance | 151.81K | 0.00% | -93.49K |
| Susquehanna group, llp | 91.03K | - | -43.35K |
| Marquette asset management | - | - | -33.31K |
| D. e. shaw | 38.57K | 0.00% | -31.94K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| World equity group | 20.00K | 0.01% | 20.00K | $48.40K |
| Wealthfront advisers | 8.69K | 0.00% | 8.69K | $974.14K |
| Simplex trading | 3.86K | - | 3.86K | $9.00K |
| National bank of canada /fi/ | 2.50K | - | 2.50K | $6.05K |
| Golden state wealth management | 303.00 | 0.00% | 303.00 | $733.00 |
Sold Out
| Holder | Change |
|---|---|
| Innealta capital | -13.00 |
| Mather group, llc. | -100.00 |
| Global retirement partners | -100.00 |
| Qube research | -107.00 |
| Tyler-stone wealth management | -300.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 23 | -59.65% | 3,266,676 | -53.06% | 7 | 2.70% | 13 | -40.91% | 2 | -85.71% |
| Sep 30, 2024 | 56 | -3.45% | 6,959,416 | 17.28% | 17 | 7.99% | 22 | - | 14 | - |
| Jun 30, 2024 | 58 | 9.43% | 5,933,790 | 12.77% | 14 | 8.67% | 22 | 4.76% | 14 | - |
| Mar 31, 2024 | 53 | -10.17% | 5,261,693 | 2.01% | 13 | 8.00% | 21 | -19.23% | 14 | 27.27% |
| Dec 31, 2023 | 59 | 1.72% | 5,157,843 | 124.71% | 12 | 39.17% | 26 | -3.70% | 11 | -15.38% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| RBC Microcap Value I | 85.30K | 0.21% | 85.30K |
| iShares Micro-Cap ETF | 84.05K | 0.21% | - |
| SPDR® Portfolio Developed Wld ex-US ETF | 53.18K | 0.13% | - |
| Dimensional US Core Equity 2 ETF | 31.86K | 0.08% | - |
| MTF TR TA-Growth | 29.23K | 0.07% | -1.13K |
| I.B.I 70/30 | 26.00K | 0.06% | - |
| Fidelity Nasdaq Composite Index | 25.45K | 0.06% | - |
| Dimensional US Targeted Value ETF | 23.87K | 0.06% | - |
| DFA US Core Equity 2 I | 23.35K | 0.06% | - |
| Avantis US Small Cap Equity ETF | 15.44K | 0.04% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 03, 2023 | Mayer Arie | - | Buy | $11.12K |
| Apr 04, 2023 | Mayer Arie | - | Buy | $8.40K |
| Mar 16, 2023 | KIDRON NADAV | President and CEO | Buy | $53.01K |
| Mar 14, 2023 | KIDRON NADAV | President and CEO | Buy | $201.00K |
| Mar 14, 2023 | Kidron Miriam | Chief Scientific Officer | Sell | $201.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q2 | 2 | - |
ORMP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools